111 related articles for article (PubMed ID: 12213509)
1. Effects of the selective dopamine D(1) antagonists NNC 01-0112 and SCH 39166 on latent inhibition in the rat.
Trimble KM; Bell R; King DJ
Physiol Behav; 2002 Sep; 77(1):115-23. PubMed ID: 12213509
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of latent inhibition in the rat by the atypical antipsychotic agent remoxipride.
Trimble KM; Bell R; King DJ
Pharmacol Biochem Behav; 1997 Apr; 56(4):809-16. PubMed ID: 9130309
[TBL] [Abstract][Full Text] [Related]
3. Effect of a dopamine D1/5 receptor antagonist on haloperidol-induced inhibition of the acquisition of conditioned fear.
Inoue T; Izumi T; Li XB; Kitaichi Y; Nakagawa S; Koyama T
Eur J Pharmacol; 2005 Sep; 519(3):253-8. PubMed ID: 16135362
[TBL] [Abstract][Full Text] [Related]
4. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
5. Impairments of movement initiation and execution induced by a blockade of dopamine D1 or D2 receptors are reversed by a blockade of N-methyl-D-aspartate receptors.
Hauber W
Neuroscience; 1996 Jul; 73(1):121-30. PubMed ID: 8783236
[TBL] [Abstract][Full Text] [Related]
6. Evidence for dopamine D(1) receptor involvement in the stimulus selection task: overshadowing in the rat.
O'Tuathaigh CM; Moran PM
Psychopharmacology (Berl); 2002 Jul; 162(3):225-31. PubMed ID: 12122479
[TBL] [Abstract][Full Text] [Related]
7. Effect of the dopamine D(1/5) antagonist SCH 23390 on the acquisition of conditioned fear.
Inoue T; Izumi T; Maki Y; Muraki I; Koyama T
Pharmacol Biochem Behav; 2000 Jul; 66(3):573-8. PubMed ID: 10899372
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.
Warburton EC; Joseph MH; Feldon J; Weiner I; Gray JA
Psychopharmacology (Berl); 1994 May; 114(4):657-64. PubMed ID: 7855229
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists.
Nielsen EB; Andersen PH
Eur J Pharmacol; 1992 Aug; 219(1):35-44. PubMed ID: 1397048
[TBL] [Abstract][Full Text] [Related]
10. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.
Weiner I; Shadach E; Barkai R; Feldon J
Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387
[TBL] [Abstract][Full Text] [Related]
11. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of the discriminative stimulus properties of cocaine with the combination of a dopamine D1 and D2 antagonist.
Meert TF; De Haes P; Aerts N; Clincke G
Acta Neurobiol Exp (Wars); 1996; 56(4):897-905. PubMed ID: 9033125
[TBL] [Abstract][Full Text] [Related]
13. Clozapine, SCH 23390 and alpha-flupenthixol but not haloperidol attenuate acute phencyclidine-induced disruption of conditional discrimination performance.
Dunn MJ; Killcross S
Psychopharmacology (Berl); 2007 Mar; 190(4):403-14. PubMed ID: 17237918
[TBL] [Abstract][Full Text] [Related]
14. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
15. Dopamine on D2-like receptors "reboosts" dopamine D1-like receptor-mediated behavioural activation in rats licking for sucrose.
D'Aquila PS
Neuropharmacology; 2010 Jun; 58(7):1085-96. PubMed ID: 20149807
[TBL] [Abstract][Full Text] [Related]
16. Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning.
Joseph MH; Peters SL; Moran PM; Grigoryan GA; Young AM; Gray JA
Neuroscience; 2000; 101(4):921-30. PubMed ID: 11113341
[TBL] [Abstract][Full Text] [Related]
17. Effects of dopamine antagonists on the timing of two intervals.
Drew MR; Fairhurst S; Malapani C; Horvitz JC; Balsam PD
Pharmacol Biochem Behav; 2003 Apr; 75(1):9-15. PubMed ID: 12759108
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 receptor involvement in latent inhibition and overshadowing.
Nelson AJ; Thur KE; Cassaday HJ
Int J Neuropsychopharmacol; 2012 Nov; 15(10):1513-23. PubMed ID: 22176724
[TBL] [Abstract][Full Text] [Related]
19. Dopamine manipulations limited to preexposure are sufficient to modulate latent inhibition.
Bethus I; Muscat R; Goodall G
Behav Neurosci; 2006 Jun; 120(3):554-62. PubMed ID: 16768607
[TBL] [Abstract][Full Text] [Related]
20. Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C.
Daly SA; Waddington JL
Psychopharmacology (Berl); 1993; 113(1):45-50. PubMed ID: 7862827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
